ARCHIVES

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

This article is from The Cancer Letter archive.

Vol. 22 No. 21 | May 24, 1996

Download PDF Visit The Full Archive

Related Articles

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

In Brief: NCAB Dec. Meeting Includes Biologics Symposium; Epidemiology Center Grant Program Disapproved

November 29, 1985

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

President Signs Supplemental Funding For NIH And FDA.

July 11, 2008

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

Young Takes Over Centers & Community Oncology, Says Biggest Problem Is Getting Adequate Funds

April 8, 1988